+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Generalized Anxiety Disorder Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 94 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5728255
This report describes the global market size of Generalized Anxiety Disorder Therapeutics from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • paroxetine
  • sertraline
  • citalopram
  • others

Companies Covered:

  • VistaGen Therapeutics
  • Bionomics
  • Arvelle Therapeutics
  • ATAI Life Sciences
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Generalized Anxiety Disorder Therapeutics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Generalized Anxiety Disorder Therapeutics Market in North America (2019-2029)
8.1 Generalized Anxiety Disorder Therapeutics Market Size
8.2 Generalized Anxiety Disorder Therapeutics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Generalized Anxiety Disorder Therapeutics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Generalized Anxiety Disorder Therapeutics Market in South America (2019-2029)
9.1 Generalized Anxiety Disorder Therapeutics Market Size
9.2 Generalized Anxiety Disorder Therapeutics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Generalized Anxiety Disorder Therapeutics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Generalized Anxiety Disorder Therapeutics Market in Asia & Pacific (2019-2029)
10.1 Generalized Anxiety Disorder Therapeutics Market Size
10.2 Generalized Anxiety Disorder Therapeutics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Generalized Anxiety Disorder Therapeutics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Generalized Anxiety Disorder Therapeutics Market in Europe (2019-2029)
11.1 Generalized Anxiety Disorder Therapeutics Market Size
11.2 Generalized Anxiety Disorder Therapeutics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Generalized Anxiety Disorder Therapeutics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Generalized Anxiety Disorder Therapeutics Market in MEA (2019-2029)
12.1 Generalized Anxiety Disorder Therapeutics Market Size
12.2 Generalized Anxiety Disorder Therapeutics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Generalized Anxiety Disorder Therapeutics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Generalized Anxiety Disorder Therapeutics Market (2019-2024)
13.1 Generalized Anxiety Disorder Therapeutics Market Size
13.2 Generalized Anxiety Disorder Therapeutics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Generalized Anxiety Disorder Therapeutics Market Size by Type
Chapter 14 Global Generalized Anxiety Disorder Therapeutics Market Forecast (2024-2029)
14.1 Generalized Anxiety Disorder Therapeutics Market Size Forecast
14.2 Generalized Anxiety Disorder Therapeutics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Generalized Anxiety Disorder Therapeutics Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 VistaGen Therapeutics
15.1.1 Company Profile
15.1.2 Main Business and Generalized Anxiety Disorder Therapeutics Information
15.1.3 SWOT Analysis of VistaGen Therapeutics
15.1.4 VistaGen Therapeutics Generalized Anxiety Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.2 Bionomics
15.2.1 Company Profile
15.2.2 Main Business and Generalized Anxiety Disorder Therapeutics Information
15.2.3 SWOT Analysis of Bionomics
15.2.4 Bionomics Generalized Anxiety Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.3 Arvelle Therapeutics
15.3.1 Company Profile
15.3.2 Main Business and Generalized Anxiety Disorder Therapeutics Information
15.3.3 SWOT Analysis of Arvelle Therapeutics
15.3.4 Arvelle Therapeutics Generalized Anxiety Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.4 ATAI Life Sciences
15.4.1 Company Profile
15.4.2 Main Business and Generalized Anxiety Disorder Therapeutics Information
15.4.3 SWOT Analysis of ATAI Life Sciences
15.4.4 ATAI Life Sciences Generalized Anxiety Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Generalized Anxiety Disorder Therapeutics Report
Table Data Sources of Generalized Anxiety Disorder Therapeutics Report
Table Major Assumptions of Generalized Anxiety Disorder Therapeutics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Generalized Anxiety Disorder Therapeutics Picture
Table Generalized Anxiety Disorder Therapeutics Classification
Table Generalized Anxiety Disorder Therapeutics Applications
Table Drivers of Generalized Anxiety Disorder Therapeutics Market
Table Restraints of Generalized Anxiety Disorder Therapeutics Market
Table Opportunities of Generalized Anxiety Disorder Therapeutics Market
Table Threats of Generalized Anxiety Disorder Therapeutics Market
Table COVID-19 Impact For Generalized Anxiety Disorder Therapeutics Market
Table Raw Materials Suppliers
Table Different Production Methods of Generalized Anxiety Disorder Therapeutics
Table Cost Structure Analysis of Generalized Anxiety Disorder Therapeutics
Table Key End Users
Table Latest News of Generalized Anxiety Disorder Therapeutics Market
Table Merger and Acquisition
Table Planned/Future Project of Generalized Anxiety Disorder Therapeutics Market
Table Policy of Generalized Anxiety Disorder Therapeutics Market
Table 2019-2029 North America Generalized Anxiety Disorder Therapeutics Market Size
Figure 2019-2029 North America Generalized Anxiety Disorder Therapeutics Market Size and CAGR
Table 2019-2029 North America Generalized Anxiety Disorder Therapeutics Market Size by Application
Table 2019-2024 North America Generalized Anxiety Disorder Therapeutics Key Players Revenue
Table 2019-2024 North America Generalized Anxiety Disorder Therapeutics Key Players Market Share
Table 2019-2029 North America Generalized Anxiety Disorder Therapeutics Market Size by Type
Table 2019-2029 United States Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Canada Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Mexico Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 South America Generalized Anxiety Disorder Therapeutics Market Size
Figure 2019-2029 South America Generalized Anxiety Disorder Therapeutics Market Size and CAGR
Table 2019-2029 South America Generalized Anxiety Disorder Therapeutics Market Size by Application
Table 2019-2024 South America Generalized Anxiety Disorder Therapeutics Key Players Revenue
Table 2019-2024 South America Generalized Anxiety Disorder Therapeutics Key Players Market Share
Table 2019-2029 South America Generalized Anxiety Disorder Therapeutics Market Size by Type
Table 2019-2029 Brazil Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Argentina Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Chile Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Peru Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Asia & Pacific Generalized Anxiety Disorder Therapeutics Market Size
Figure 2019-2029 Asia & Pacific Generalized Anxiety Disorder Therapeutics Market Size and CAGR
Table 2019-2029 Asia & Pacific Generalized Anxiety Disorder Therapeutics Market Size by Application
Table 2019-2024 Asia & Pacific Generalized Anxiety Disorder Therapeutics Key Players Revenue
Table 2019-2024 Asia & Pacific Generalized Anxiety Disorder Therapeutics Key Players Market Share
Table 2019-2029 Asia & Pacific Generalized Anxiety Disorder Therapeutics Market Size by Type
Table 2019-2029 China Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 India Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Japan Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 South Korea Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Southeast Asia Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Australia Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Europe Generalized Anxiety Disorder Therapeutics Market Size
Figure 2019-2029 Europe Generalized Anxiety Disorder Therapeutics Market Size and CAGR
Table 2019-2029 Europe Generalized Anxiety Disorder Therapeutics Market Size by Application
Table 2019-2024 Europe Generalized Anxiety Disorder Therapeutics Key Players Revenue
Table 2019-2024 Europe Generalized Anxiety Disorder Therapeutics Key Players Market Share
Table 2019-2029 Europe Generalized Anxiety Disorder Therapeutics Market Size by Type
Table 2019-2029 Germany Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 France Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 United Kingdom Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Italy Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Spain Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Belgium Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Netherlands Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Austria Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Poland Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Russia Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 MEA Generalized Anxiety Disorder Therapeutics Market Size
Figure 2019-2029 MEA Generalized Anxiety Disorder Therapeutics Market Size and CAGR
Table 2019-2029 MEA Generalized Anxiety Disorder Therapeutics Market Size by Application
Table 2019-2024 MEA Generalized Anxiety Disorder Therapeutics Key Players Revenue
Table 2019-2024 MEA Generalized Anxiety Disorder Therapeutics Key Players Market Share
Table 2019-2029 MEA Generalized Anxiety Disorder Therapeutics Market Size by Type
Table 2019-2029 Egypt Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Israel Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 South Africa Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Gulf Cooperation Council Countries Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2029 Turkey Generalized Anxiety Disorder Therapeutics Market Size
Table 2019-2024 Global Generalized Anxiety Disorder Therapeutics Market Size by Region
Table 2019-2024 Global Generalized Anxiety Disorder Therapeutics Market Size Share by Region
Table 2019-2024 Global Generalized Anxiety Disorder Therapeutics Market Size by Application
Table 2019-2024 Global Generalized Anxiety Disorder Therapeutics Market Share by Application
Table 2019-2024 Global Generalized Anxiety Disorder Therapeutics Key Vendors Revenue
Figure 2019-2024 Global Generalized Anxiety Disorder Therapeutics Market Size and Growth Rate
Table 2019-2024 Global Generalized Anxiety Disorder Therapeutics Key Vendors Market Share
Table 2019-2024 Global Generalized Anxiety Disorder Therapeutics Market Size by Type
Table 2019-2024 Global Generalized Anxiety Disorder Therapeutics Market Share by Type
Table 2024-2029 Global Generalized Anxiety Disorder Therapeutics Market Size by Region
Table 2024-2029 Global Generalized Anxiety Disorder Therapeutics Market Size Share by Region
Table 2024-2029 Global Generalized Anxiety Disorder Therapeutics Market Size by Application
Table 2024-2029 Global Generalized Anxiety Disorder Therapeutics Market Share by Application
Table 2024-2029 Global Generalized Anxiety Disorder Therapeutics Key Vendors Revenue
Figure 2024-2029 Global Generalized Anxiety Disorder Therapeutics Market Size and Growth Rate
Table 2024-2029 Global Generalized Anxiety Disorder Therapeutics Key Vendors Market Share
Table 2024-2029 Global Generalized Anxiety Disorder Therapeutics Market Size by Type
Table 2024-2029 Generalized Anxiety Disorder Therapeutics Global Market Share by Type

Companies Mentioned

  • VistaGen Therapeutics
  • Bionomics
  • Arvelle Therapeutics
  • ATAI Life Sciences

Methodology

Loading
LOADING...